
BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
6 Top of the line Lodgings All over The Planet, Which One Do You Concur With - 2
Which Switch Game Do You Suggest? Share Your Decision - 3
25 Years Ago, Audi's Rosemeyer Concept Was A Steampunk Supercar With A Massive Engine - 4
Flu surges across U.S. as doctor visits reach highest level since 1997 - 5
Key Caper d: A Survey of \Procedure and Tomfoolery Released\ Tabletop game
Tire Brands for Senior Drivers: Guaranteeing Security and Solace
Manageable Living: Eco-Accommodating Decisions for Regular day to day existence
6 Methods for further developing Rest Quality
Golden Globes 2026 full nominations list: 'One Battle After Another' and 'The White Lotus' lead in film and television categories
Vote in favor of Your Number one Cake Type
Bomb blast in packed Nigerian mosque kills five
Metropolitan Greatness: The 6 Urban areas for Quality Living in 2024
Did we start the fire? A 400,000-year-old hearth sparks new questions about human evolution
I binged all 24 Hallmark Christmas movies in less than 30 days. I emerged a changed man.













